Teva et Alvotech lancent la première haute concentration interchangeable. Teva and Alvotech launch the first interchangeable high-concentration.

Teva Pharmaceuticals et Alvotech ont annoncé la disponibilité de SIMLANDI (adalimumab-ryvk), le premier biosimilaire interchangeable à haute concentration et sans citrate d'Humira, aux États-Unis. Teva Pharmaceuticals and Alvotech have announced the availability of SIMLANDI (adalimumab-ryvk), the first interchangeable high-concentration, citrate-free biosimilar to Humira, in the US. Il est indiqué pour le traitement de diverses maladies auto-immunes comme la polyarthrite rhumatoïde, le rhumatisme psoriasique, la maladie de Crohn, la colite ulcéreuse, le psoriasis en plaques, l'hidradénite suppurée et l'uvéite. It is indicated for the treatment of various autoimmune conditions like rheumatoid arthritis, psoriatic arthritis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and uveitis.

May 21, 2024

7 Articles